+948.4%
MRNA vs VRSN
+99.3%
+849.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VRSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.3% | -2.2% |
| 7D | -12.7% | -1.7% | -11.0% | -12.3% |
| 30D | -20.7% | +0.1% | -20.8% | -20.7% |
| 3M | +46.3% | +11.1% | +35.1% | +42.3% |
| 6M | +305.2% | +1.8% | +303.4% | +300.9% |
| YTD | +561.2% | +27.8% | +533.4% | +499.6% |
| 1Y | +772.1% | +25.0% | +747.1% | +697.0% |
| 3Y | +147.0% | +48.6% | +98.4% | +108.1% |
| 5Y | -26.1% | +27.5% | -53.6% | -36.8% |
| All | +948.4% | +99.3% | +849.1% | +571.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSN.
Daily Out/Under-Performance
Portfolio return minus VRSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling